20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes

Z Lanietovic, MA Zmijewski, Robert Tuckey, Minh Nguyen, AT Slominski

Research output: Chapter in Book/Conference paperConference paper

Original languageEnglish
Title of host publicationJOURNAL OF INVESTIGATIVE DERMATOLOGY
PagesS20-S20
Volume128
Publication statusPublished - 2008
Event20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes -
Duration: 1 Jan 2008 → …

Conference

Conference20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes
Period1/01/08 → …

Cite this

@inproceedings{969f597465ab4825b889c8272192fe70,
title = "20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes",
author = "Z Lanietovic and MA Zmijewski and Robert Tuckey and Minh Nguyen and AT Slominski",
year = "2008",
language = "English",
volume = "128",
pages = "S20--S20",
booktitle = "JOURNAL OF INVESTIGATIVE DERMATOLOGY",

}

Lanietovic, Z, Zmijewski, MA, Tuckey, R, Nguyen, M & Slominski, AT 2008, 20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes. in JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 128, pp. S20-S20, 20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes, 1/01/08.

20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes. / Lanietovic, Z; Zmijewski, MA; Tuckey, Robert; Nguyen, Minh; Slominski, AT.

JOURNAL OF INVESTIGATIVE DERMATOLOGY. Vol. 128 2008. p. S20-S20.

Research output: Chapter in Book/Conference paperConference paper

TY - GEN

T1 - 20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes

AU - Lanietovic, Z

AU - Zmijewski, MA

AU - Tuckey, Robert

AU - Nguyen, Minh

AU - Slominski, AT

PY - 2008

Y1 - 2008

M3 - Conference paper

VL - 128

SP - S20-S20

BT - JOURNAL OF INVESTIGATIVE DERMATOLOGY

ER -